Position in LNTH
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$49,590
+$15,382 QoQ
Shares Held
447
-0.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 124 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $6,951,552 across 44 Drug Manufacturers - Specialty & Generic names. LNTH ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
143,876 | $4,874,518 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,544 | $836,585 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
3,008 | $506,968 | |
| 4 | ZTS |
Zoetis Inc.
|
2,994 | $215,148 | |
| 5 | LQDA |
Liquidia Corp
|
950 | $75,743 | |
| 6 | CTOR |
Citius Oncology, Inc.
|
107,424 | $69,825 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
This page
|
447 | $49,590 | |
| 8 | VTRS |
Viatris Inc
|
2,398 | $38,080 |
All Filings in LNTH
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,590 | 447 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $34,208 | 451 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $32,476 | 488 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $124,224 | 2,422 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $80,959 | 989 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $96,526 | 989 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $98,495 | 1,101 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,174,215 | 10,699 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $848,665 | 10,570 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $756,713 | 12,158 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $783,928 | 12,644 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $329,335 | 4,740 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $262,921 | 3,133 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $288,960 | 3,500 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $327,316 | 6,423 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $573,259 | 8,151 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $434,741 | 6,584 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $364,161 | 6,584 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $101,115 | 3,500 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $89,880 | 3,500 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $96,740 | 3,500 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $74,795 | 3,500 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $47,215 | 3,500 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $57,015 | 4,500 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $64,350 | 4,500 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $57,420 | 4,500 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||